The future of CRISPR in Mycobacterium tuberculosis infection - Institut Polytechnique de Paris Accéder directement au contenu
Article Dans Une Revue (Article De Synthèse) Journal of Biomedical Science Année : 2023

The future of CRISPR in Mycobacterium tuberculosis infection

Résumé

Clustered Regularly Interspaced Short Palindromic repeats (CRISPR)-Cas systems rapidly raised from a bacterial genetic curiosity to the most popular tool for genetic modifications which revolutionized the study of microbial physiology. Due to the highly conserved nature of the CRISPR locus in Mycobacterium tuberculosis , the etiological agent of one of the deadliest infectious diseases globally, initially, little attention was paid to its CRISPR locus, other than as a phylogenetic marker. Recent research shows that M. tuberculosis has a partially functional Type III CRISPR, which provides a defense mechanism against foreign genetic elements mediated by the ancillary RNAse Csm6. With the advent of CRISPR-Cas based gene edition technologies, our possibilities to explore the biology of M. tuberculosis and its interaction with the host immune system are boosted. CRISPR-based diagnostic methods can lower the detection threshold to femtomolar levels, which could contribute to the diagnosis of the still elusive paucibacillary and extrapulmonary tuberculosis cases. In addition, one-pot and point-of-care tests are under development, and future challenges are discussed. We present in this literature review the potential and actual impact of CRISPR-Cas research on human tuberculosis understanding and management. Altogether, the CRISPR-revolution will revitalize the fight against tuberculosis with more research and technological developments.
Fichier principal
Vignette du fichier
The future of CRISPR in Mycobacterium tuberculosis infection.pdf (1.75 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04117515 , version 1 (05-06-2023)

Identifiants

Citer

Rima Zein Eddine, Guislaine Refrégier, Jorge Cervantes, Noemí Kaoru Yokobori. The future of CRISPR in Mycobacterium tuberculosis infection. Journal of Biomedical Science, 2023, 30 (1), pp.34. ⟨10.1186/s12929-023-00932-4⟩. ⟨hal-04117515⟩
55 Consultations
25 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More